We believe pets deserve more therapeutics developed and approved specifically for them.
Only 15% of pet diseases have an approved treatment. We’re working on therapeutics for the other 85%.
Anivive Lifesciences, Inc. is a next generation animal health company.
We combine artificial intelligence software, biotech, and veterinary medicine to serve the unmet medical needs of pets with a diverse pipeline of innovative products to treat cancers, infectious diseases, and endocrine conditions.
Using proprietary software and predictive analytics, Anivive is accelerating the discovery, development, and commercialization of new, affordable treatments for pets.
LAVERDIA™-CA1, the first oral tablet conditionally approved by the FDA to lymphoma in dogs has shipped to over 475 veterinary oncology clinics.
As part of a partnership with Mars Veterinary Health, board-certified oncologists at VCA and BluePearl pet hospital were the first to receive and prescribe LAVERDIA™-CA1 in May 2021. LAVERDIA™-CA1 uses novel SINE technology to target cancer cells and slow their rapid replication.
The impact of canine lymphoma
Lymphoma is the most common cancer in dogs—and traditional therapies have not changed in decades.
1 in 5 cancer diagnoses is lymphoma
8 in 10 dogs are untreated due to side effects and costs over $5k
30-day life expectancy without chemotherapy
Valley fever is currently not preventable — and spreading
Anivive's Valley fever vaccine demonstrated efficacy in laboratory studies and now awaits completion of a field safety study prior to submission for approval.
The vaccine is designed to be given as an injection, the same way dogs receive other vaccines, with two injections the first year, and a single booster annually.
The impact of
Valley fever is caused by a soil borne fungi that thrives in semiarid regions and is expanding across the Western US.
Reportable fungal disease in western US
Even when treated, infection can recur and cause debilitations or death
In reported cases since the year 2000, with spread linked to climate change